BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2871096)

  • 1. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Waldvogel FA
    J Hosp Infect; 1986 Mar; 7 Suppl A():37-46. PubMed ID: 2871096
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
    Watanakunakorn C
    Ann Intern Med; 1982 Sep; 97(3):376-8. PubMed ID: 7114635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial therapy.
    Feingold DS; Wagner RF
    J Am Acad Dermatol; 1986 Apr; 14(4):535-48. PubMed ID: 3514701
    [No Abstract]   [Full Text] [Related]  

  • 4. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
    Klastersky J; Van der Auwera P
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of methicillin-resistant Staphylococcus aureus.
    Wenzel RP
    Ann Intern Med; 1982 Sep; 97(3):440-2. PubMed ID: 7114639
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of mice infected with methicillin-resistant Staphylococcus aureus.
    Moorman DR; Peacock JE; Mandell GL
    Chemotherapy; 1982; 28(4):294-7. PubMed ID: 7116982
    [No Abstract]   [Full Text] [Related]  

  • 7. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
    Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; LondoƱo A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
    Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?
    Milatovic D
    Eur J Clin Microbiol; 1986 Dec; 5(6):689-92. PubMed ID: 3643105
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
    Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
    Harvey K; Pavillard R
    Med J Aust; 1982 May; 1(11):465-7. PubMed ID: 7048040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New indications for old antibiotics: tetracycline, erythromycin, carbenicillin, and vancomycin revisited.
    Gleckman RA; Esposito AL
    South Med J; 1979 Jun; 72(6):721-5. PubMed ID: 36669
    [No Abstract]   [Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus: clinical and laboratory features.
    Aldridge KE
    Infect Control; 1985 Nov; 6(11):461-5. PubMed ID: 3851787
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection.
    Eng RH; Smith SM; Tillem M; Cherubin C
    Arch Intern Med; 1985 Jan; 145(1):146-8. PubMed ID: 3844314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin for Staphylococcus aureus therapy of respiratory tract infections: the end of an era?
    Nathwani D; Tillotson GS
    Int J Antimicrob Agents; 2003 Jun; 21(6):521-4. PubMed ID: 12791464
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of teicoplanin in localized experimental infections in rats.
    Arioli V; Berti M; Candiani G
    J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
    Ju O; Woolley M; Gordon D
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):61-2. PubMed ID: 16331332
    [No Abstract]   [Full Text] [Related]  

  • 19. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
    Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.